Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma

NCT06642506 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Esophagus Adenocarcinoma
Esophagus Cancer
Metabolome
Mass Spectrometry
Precision Medicine
Oncology Patients Receiving Chemotherapy
Metabolomics
Chemoresistance

Sponsor

Ludwig-Maximilians - University of Munich

Collaborators

[object Object]
[object Object]